{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-014650","form_type":"8-K","ticker":"CALC","cik":"0001534133","company_name":"CalciMedica, Inc.","filed_at":"2022-04-18T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.104865+00:00","generated_at":"2026-06-26T06:53:55.168983+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Graybug Vision appoints Dirk Sauer to board; Gerald Cagle resigns as director","bullets":["Gerald Cagle resigned as director and from Nominating and Governance Committee effective April 13, 2022; will remain as paid advisor.","Dirk Sauer appointed to board to fill vacancy, will serve as Class I director, expected to stand for election at 2024 annual meeting.","Sauer will chair newly formed Science and Innovation Committee; compensation includes $40k annual retainer, $4k committee fee, and 80,000 share option grant vesting over 3 years.","Sauer brings 30+ years ophthalmic drug development experience, previously led Novartis Ophthalmology Development Unit."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-014650","json":"https://secwatch.observer/filing/0001564590-22-014650.json","markdown":"https://secwatch.observer/filing/0001564590-22-014650.md","text":"https://secwatch.observer/filing/0001564590-22-014650.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534133/000156459022014650/0001564590-22-014650-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534133/000156459022014650/gray-8k_20220413.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T06:53:55.168983+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"725142bb3c","claim":"Gerald D. Cagle resigned as Director at CalciMedica, Inc..","evidence_excerpt":"On April 13, 2022, the Board of Directors (the “Board”) of Graybug Vision, Inc. (the “Company”) received a letter from Gerald D. Cagle, Ph.D resigning as a director of the Company and as a member of the Nominating and Corporate Governance Committee of the Board, effective as of that day.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1534133/000156459022014650/0001564590-22-014650-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"7914274ab0","claim":"Dirk Sauer was appointed as Director at CalciMedica, Inc..","evidence_excerpt":"On April 13, 2022 (the “Effective Date”) , the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Dirk Sauer, Ph.D, age 62, to serve as a member of the Board to fill the vacancy that was created by the resignation of Dr. Cagle described above.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1534133/000156459022014650/0001564590-22-014650-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}